ロード中...
Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer
We present a case of a 59-year-old male with a confirmed diagnosis of small-cell lung cancer (SCLC). He had progressive disease even after four cycles of cisplatin and etoposide chemotherapy and 21 cycles of radiation. He was therefore started on immunotherapy with nivolumab every 2 weeks and ipilim...
保存先:
| 出版年: | Case Rep Neurol Med |
|---|---|
| 主要な著者: | , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6633879/ https://ncbi.nlm.nih.gov/pubmed/31355029 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2019/5353202 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|